Common Stock, Shares, Outstanding of ADIAL PHARMACEUTICALS, INC. from 31 Dec 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
ADIAL PHARMACEUTICALS, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2017 to 31 Dec 2025.
  • ADIAL PHARMACEUTICALS, INC. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 1,111,010, a 329% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

ADIAL PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 1,111,010 +852,184 +329% 31 Dec 2025 10-K 05 Mar 2026 2025 FY
Q3 2025 23,836,383 +17,430,602 +272% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 21,534,695 +17,241,014 +402% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 6,649,588 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 258,826 -1,404,595 -84% 31 Dec 2024 10-K 05 Mar 2026 2025 FY
Q3 2024 6,405,781 +5,187,800 +426% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 4,293,681 +3,096,051 +259% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q4 2023 1,663,421 +595,930 +56% 31 Dec 2023 10-K 04 Mar 2025 2024 FY
Q3 2023 1,217,981 -25,635,981 -95% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 1,197,630 -24,656,332 -95% 30 Jun 2023 10-Q/A 30 Oct 2023 2023 Q2
Q1 2023 28,516,564 +4,797,602 +20% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 1,067,491 -19,879,221 -95% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 26,853,962 +6,405,806 +31% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 25,853,962 +7,448,236 +40% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 23,718,962 +6,449,085 +37% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 20,946,712 +6,553,612 +46% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 20,448,156 +6,230,056 +44% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 18,405,726 +4,956,123 +37% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 17,269,877 +6,640,274 +62% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 14,393,100 +4,024,748 +39% 31 Dec 2020 10-K 28 Mar 2022 2021 FY
Q3 2020 14,218,100 +3,923,240 +38% 30 Sep 2020 10-Q 13 Nov 2020 2020 Q3
Q2 2020 13,449,603 +3,207,154 +31% 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 10,629,603 +460,777 +4.5% 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 10,368,352 +3,505,853 +51% 31 Dec 2019 10-K 22 Mar 2021 2020 FY
Q3 2019 10,294,860 +3,738,611 +57% 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 10,242,449 +6,682,135 +188% 30 Jun 2019 10-Q 13 Aug 2019 2019 Q2
Q1 2019 10,168,826 31 Mar 2019 10-Q 13 May 2019 2019 Q1
Q4 2018 6,862,499 +3,594,494 +110% 31 Dec 2018 10-K 20 Mar 2020 2019 FY
Q3 2018 6,556,249 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 3,560,314 30 Jun 2018 10-Q 10 Sep 2018 2018 Q2
Q4 2017 3,268,005 31 Dec 2017 10-K 19 Feb 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.